Dec. 13, 2017
NewsCompany News

Zeiss Continues Growth

  • Zeiss continues its growth trajectory in fiscal year 2016/17. At the annual press conference in Stuttgart Prof. Dr. Michael Kaschke, President and CEO of Carl Zeiss AG, announces a new record in both revenue and earnings.Zeiss continues its growth trajectory in fiscal year 2016/17. At the annual press conference in Stuttgart Prof. Dr. Michael Kaschke, President and CEO of Carl Zeiss AG, announces a new record in both revenue and earnings.

In the past 2016/17 fiscal year (ended 30 September 2017), Zeiss increased both its revenue and earnings to a record level: revenue rose by 10 percent to EUR 5.348 billion (prior year: EUR 4.881 billion). At EUR 770 million, earnings before interest and tax (EBIT) were significantly above the already high level of the previous year (615 million). The EBIT margin has increased to over 14 percent. Order intake grew by a healthy 12 percent and is now at EUR 5.625 billion, underscoring the growth ambitions of the technology company.

"All four segments – Research & Quality Technology, Medical Technology, Vision Care/Consumer Products and Semiconductor Manufacturing Technology – are either at or above their target returns and have made a positive contribution to the most successful fiscal year in the history of Zeiss," said Prof. Dr. Michael Kaschke, President & CEO of Carl Zeiss AG, at the annual press conference in Stuttgart. "This development was not and is not just a matter of course. Rather, it is the result of the tremendous efforts made by all employees and partners over a long period of time. The consistent implementation of the strategic Agenda has now made a real impact and significantly increased competitiveness. Thanks to investments in cutting-edge Innovation and Customer Centers, global partnerships and strategic expansions, we have focused entirely on the needs of our customers," said Kaschke, explaining the company's strategy.

Financial Highlights

Zeiss generates just under 90 percent of its business outside Germany. Asia/Pacific (APAC) remains the largest growth region with a revenue of EUR 1.270 billion. This corresponds to an increase of 15 percent over the previous year after currency adjustments (1.123 billion). Revenue amounted to EUR 598 million in China alone (prior year: 504 million). The revenue in emerging economies after currency adjustments has exceeded the billion euro mark, reaching EUR 1.181 billion (prior year: 995 million). The company's German sites have also benefited from the enormous growth in these markets. The largest single market for Zeiss remains the US with approximately EUR 1 billion.

In fiscal year 2016/17, the company increased its investments in research and development by around 27 percent to 552 million (prior year: 436 million).

Investments in property, plant and equipment were increased to 183 million (prior year: 154 million). This compared to depreciations totaling EUR 160 million (prior year: 155 million). "Zeiss’s bold, global investment strategy is a key pillar of our long-term growth trajectory. Since 2010, we have spent around EUR 1.45 million on this," says Thomas Spitzenpfeil, CFO of Carl Zeiss AG.

Net liquidity has increased significantly and was at EUR 1.986 billion as of the reporting date (30 September 2016: 568 million). In particular ASML's stake in Carl Zeiss SMT and a capital increase at Carl Zeiss Meditec AG have played a major role in strengthening liquidity. The company's equity is at EUR 3.429 billion, equaling an almost doubled equity ratio of 47 percent. Thanks to a greater inventories and increased receivables, free cash flow is at EUR 658 million (prior year: 709 million) in spite of the increased EBIT.

More information:
https://www.zeiss.com

You may also be interested in

Register now!

The latest information directly via newsletter.

To prevent automated spam submissions leave this field empty.